Prednisolone Acetate Eye Drop Injury Lawsuits

FDA Recalls More Than 2.5 Million Bottles of Prednisolone Acetate Eye Drops Over Foreign Substance

What Parker Waichman LLP Found

• More than 2.5 million bottles are reportedly affected. The nationwide action involves Prednisolone Acetate Ophthalmic Suspension USP, 1% manufactured by Lupin Limited.
• The reported recall reason involves a foreign substance. This raises particular concerns because the medication is administered directly to the eye.
• Three bottle sizes are involved. The affected configurations include 5-mL, 10-mL, and 15-mL bottles with NDCs 70748-332-02, 70748-332-03, and 70748-332-04.
• Patients with injuries should preserve their bottles. The NDC, lot number, expiration date, and pharmacy information can become important evidence.
• A recall does not automatically establish a lawsuit. A viable injury claim generally requires evidence connecting an affected product to a medically documented injury.

More than 2.5 million bottles of prednisolone acetate ophthalmic suspension manufactured by Lupin Limited have been recalled nationwide after a foreign substance was reportedly identified in the product. The recall affects prescription corticosteroid eye drops used by patients with inflammation involving the eye, including people recovering from eye surgery and those being treated for inflammatory eye conditions.

According to the FDA enforcement information reported for the recall, approximately 2,530,182 bottles of Prednisolone Acetate Ophthalmic Suspension USP, 1% are affected. The recall covers 5-mL, 10-mL, and 15-mL bottles distributed across the United States. The FDA reportedly posted the recall on June 4, 2026, and subsequently designated it a Class II recall on June 30, 2026.

The size of this recall deserves attention. More than 2.5 million bottles means potentially affected medication may have reached pharmacies, medical facilities, eye-care practices, and patients across the country. People who currently use prednisolone acetate eye drops should determine whether their medication is included in the recall rather than assuming their prescription is unaffected.

Patients who believe they suffered an eye injury, infection, worsening vision, or another adverse medical condition after using recalled prednisolone acetate ophthalmic suspension should preserve the bottle and packaging whenever possible and seek appropriate medical attention. The bottle itself may become important evidence if an injury claim is later investigated.

What Is Prednisolone Acetate Ophthalmic Suspension?

Prednisolone acetate ophthalmic suspension is a prescription corticosteroid medication used to control inflammation involving the eye. Lupin identifies its product as Prednisolone Acetate Ophthalmic Suspension USP, 1%, an ophthalmic anti-inflammatory corticosteroid and generic equivalent of Pred Forte. The company received FDA approval for its generic version in August 2024 and subsequently announced its U.S. launch in October 2024.

The medication is indicated for steroid-responsive inflammation affecting portions of the eye including the conjunctiva, cornea, and anterior segment. Depending upon the patient’s condition, an eye-care provider may prescribe corticosteroid eye drops following surgery or to treat an inflammatory eye disorder.

Because these drops are applied directly to the eye, product quality and purity are particularly important. Unlike an oral medication that travels through the digestive system, an ophthalmic product is administered directly onto a sensitive organ. A foreign substance in an ophthalmic medication therefore presents concerns that should be evaluated carefully when a patient experiences an unexpected reaction or injury.

Patients should not assume that every symptom occurring while taking prednisolone acetate resulted from the recall. Corticosteroid ophthalmic medications themselves have known risks and potential adverse effects. Determining whether an injury resulted from an alleged product defect generally requires review of the patient’s medical records, the recalled product information, lot identification, timing of symptoms, medical diagnosis, and other possible explanations.

Which Prednisolone Acetate Eye Drops Are Included in the Recall?

The recall involves Lupin Prednisolone Acetate Ophthalmic Suspension USP, 1%, sold in three bottle sizes.

The affected product configurations are:

• 5-mL bottles: NDC 70748-332-02, involving multiple recalled lots with expiration dates reportedly ranging from July 31, 2026, through March 31, 2028.
• 10-mL bottles: NDC 70748-332-03, involving multiple recalled lots with expiration dates reportedly ranging from July 31, 2026, through January 31, 2028.
• 15-mL bottles: NDC 70748-332-04, involving multiple recalled lots with expiration dates reportedly ranging from July 31, 2026, through February 29, 2028.

Lupin’s current product information confirms that its 1% prednisolone acetate ophthalmic suspension is marketed in 5-mL, 10-mL, and 15-mL sizes under these three NDC numbers.

Because numerous individual lots are reportedly involved, patients should not rely solely upon the name of the medication or bottle size when determining whether they possess a recalled product. The NDC, lot number, and expiration date should be compared with the FDA’s current enforcement information.

Patients should also consider where older bottles may be located. A recalled bottle could remain in a medicine cabinet, travel bag, bedside drawer, postoperative care kit, or another location even after the patient has stopped using it.

Why Was Lupin Prednisolone Acetate Ophthalmic Suspension Recalled?

The reported reason for the recall is the presence of a foreign substance.

Foreign material in a pharmaceutical product raises concerns because medications are expected to satisfy manufacturing and quality standards designed to protect patients. These concerns become particularly important with ophthalmic medications because the product is administered directly to the eye.

The presence of foreign material does not mean every person who used an affected bottle will suffer an injury. It also does not establish that every medical problem occurring after use was caused by the medication. However, patients experiencing unusual eye symptoms after using an affected product should take those symptoms seriously and discuss them with an appropriate healthcare provider.

Depending on the nature of an ophthalmic product problem and the circumstances of exposure, potential concerns can include irritation, inflammation, infection, pain, redness, changes in vision, or other ocular complications. The actual medical consequences for an individual patient depend upon numerous factors, including the nature of the foreign material, the amount and duration of exposure, the patient’s underlying eye condition, and the treatment received afterward.

This distinction may become important in litigation. A recall establishes that a product was removed or corrected because of an identified regulatory problem. It does not automatically establish that a particular person’s injury was caused by that problem. Causation generally must be established using medical evidence and the facts surrounding the patient’s exposure.

What Does an FDA Class II Recall Mean?

The FDA reportedly classified the prednisolone acetate recall as Class II.

A Class II classification generally applies when use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or when the probability of serious adverse health consequences is considered remote.

That classification should not be interpreted to mean that patients can disregard the recall. A medication applied directly to the eye deserves particular attention when a patient develops new or worsening symptoms.

A Class II designation also does not determine the seriousness of an individual patient’s injury. Someone who suffers substantial medical complications may have a significant injury claim even though the broader recall is categorized as Class II.

The classification addresses the general health risk associated with the recalled product. A patient’s individual outcome must be evaluated separately.

Eye Injuries Associated With Contaminated Ophthalmic Products Can Be Serious

The eye is an exceptionally sensitive organ, and complications involving ophthalmic medications can have significant consequences.

A person using prescription steroid drops may already have a vulnerable eye because of surgery, trauma, inflammation, or another medical condition. An additional product-related problem can complicate diagnosis and treatment.

Symptoms that warrant medical evaluation can include significant or persistent eye pain, unusual redness, swelling, discharge, worsening inflammation, light sensitivity, blurred vision, decreased visual acuity, sudden changes in vision, or symptoms suggesting infection.

Patients should not attempt to determine on their own whether these symptoms resulted from the recalled medication. An ophthalmologist or other appropriate healthcare professional can examine the eye and determine what treatment may be necessary.

Medical documentation can also become critically important when an injury claim is investigated. Records showing when symptoms began, what physicians observed, diagnostic testing, treatment, medications, visual acuity measurements, and the patient’s progress can help establish what occurred following exposure.

Patients Recovering From Eye Surgery May Have Additional Concerns

Prednisolone acetate ophthalmic suspension may be prescribed following ophthalmic procedures to control postoperative inflammation. That creates a potentially important issue for patients who used recalled medication during surgical recovery.

A postoperative patient experiencing pain, inflammation, redness, or visual changes may initially assume the symptoms are simply part of normal healing. Conversely, a complication caused by surgery or the underlying condition might mistakenly be attributed to medication.

Determining the cause requires careful medical evaluation.

Patients who used a recalled bottle following cataract surgery or another ophthalmic procedure should tell their treating physician exactly which medication they used. When available, they should provide the bottle, NDC, lot number, expiration date, pharmacy information, and approximate dates of use.

Lupin’s prescribing information also identifies important considerations associated with ophthalmic corticosteroids themselves. For example, steroid use following cataract surgery may delay healing, and prolonged corticosteroid use can present other ocular risks. Separating an expected medication risk or surgical complication from an injury allegedly associated with a recalled product can therefore require detailed medical analysis.

What Should Patients Using Prednisolone Acetate Eye Drops Do?

Patients should first determine whether their medication is included in the recall.

Look at the bottle and packaging for the manufacturer, NDC, lot number, and expiration date. Compare those identifiers with current FDA recall information. Because multiple lots are affected, matching only the drug name is not sufficient.

Patients should contact their ophthalmologist, optometrist, pharmacist, prescribing physician, or other appropriate healthcare provider for instructions regarding an affected prescription. People using corticosteroid eye medication for an active medical condition should obtain medical guidance regarding treatment rather than simply making assumptions about whether therapy should be discontinued or replaced.

Anyone experiencing significant eye pain, sudden vision loss, severe visual changes, or other urgent symptoms should seek prompt medical evaluation.

Patients who believe they suffered an injury should also avoid throwing away potentially important evidence. Preserve the medication bottle, carton, pharmacy receipt, prescription information, medication instructions, photographs of the product, and any correspondence concerning the recall.

Why Preserving the Recalled Eye Drop Bottle Can Matter in a Lawsuit

Product identification can become one of the most important issues in pharmaceutical litigation.

A patient may know that they used prednisolone acetate but later be unable to establish which manufacturer produced the medication or which lot they received. Generic drugs can be manufactured by multiple companies, and pharmacies may change suppliers.

Keeping the bottle can potentially establish:

• The manufacturer of the medication.
• The NDC associated with the prescription.
• The specific lot number.
• The expiration date.
• The pharmacy dispensing information.
• Whether the product corresponds with an affected recall lot.

Patients should consider photographing all sides of the bottle and packaging so identifying information remains available even if labels deteriorate.

Pharmacy records can provide another source of evidence. Prescription histories, dispensing records, insurance records, receipts, and medical records may help establish when the drug was dispensed and used.

Potential Prednisolone Acetate Eye Drop Lawsuits

A patient who suffers an injury associated with an allegedly defective or contaminated medication may have potential claims under applicable state law.

Depending upon the circumstances and jurisdiction, litigation could involve allegations concerning manufacturing defects, product contamination, inadequate quality-control procedures, negligence, failure to provide appropriate warnings, breach of applicable duties, or other product liability theories.

A pharmaceutical recall alone does not automatically entitle every purchaser to compensation. An injury case ordinarily requires evidence connecting the allegedly defective product with an actual injury and resulting damages.

For that reason, attorneys investigating potential prednisolone acetate claims may examine the recalled bottle, pharmacy dispensing records, medical history, ophthalmology records, photographs, diagnostic tests, treatment records, lost-income documentation, and other evidence.

Potential defendants also depend upon the circumstances. An investigation may examine the manufacturer and other entities involved in producing or distributing the medication. Liability cannot be assumed merely because an entity participated somewhere in the supply chain.

What Compensation Could Be Available in an Eye Drop Injury Lawsuit?

When defective medication causes an injury, recoverable damages depend upon the applicable state law and facts of the case.

A patient who requires emergency evaluation, additional ophthalmology appointments, prescription medications, diagnostic testing, procedures, hospitalization, or surgery may incur substantial medical expenses. A serious eye injury can also interfere with employment, driving, reading, computer work, and ordinary daily activities.

Potential damages may include past and future medical expenses, lost income, diminished earning capacity, pain and suffering, and other losses permitted by applicable law.

Cases involving permanent visual impairment can be particularly significant because vision loss may fundamentally affect independence and quality of life. A person may require continuing treatment, adaptive equipment, occupational changes, or assistance performing activities that were previously routine.

Every claim must be evaluated individually. The amount potentially recoverable depends upon the nature of the injury, prognosis, evidence of causation, applicable state law, and other case-specific circumstances.

Statutes of Limitations Can Restrict the Time to File a Claim

People considering litigation should also understand that product liability and personal injury claims are subject to filing deadlines.

The applicable statute of limitations varies from state to state. Additional rules may affect when the filing period begins, particularly when an injury or its cause is not immediately apparent.

Waiting can create another problem beyond the statutory deadline: evidence can disappear.

Medication bottles may be discarded. Pharmacy records may become more difficult to obtain. Medical providers may change systems. Witnesses may forget details. Photographs, receipts, emails, and other records may be lost.

Prompt investigation can help preserve evidence and determine which legal deadlines potentially apply.

Prednisolone Acetate Eye Drop Recall Lawsuit FAQs

Can I File a Lawsuit If I Used Recalled Prednisolone Acetate Eye Drops?

Potentially. Using a recalled product alone generally does not establish a personal injury claim. A stronger potential case exists when a patient can establish that they used an affected product and subsequently suffered a medically documented injury that can reasonably be connected to the product defect. Attorneys may review the bottle, lot information, pharmacy records, medical records, timing of symptoms, diagnosis, and treatment to determine whether a potential claim exists.

What Injuries Could Potentially Lead to a Prednisolone Acetate Lawsuit?

The viability of a claim depends upon the actual injury and evidence connecting it to the recalled medication. Patients experiencing significant inflammation, infection, persistent pain, worsening vision, visual impairment, or another serious eye condition following use should obtain medical care. An attorney can then evaluate whether medical evidence supports an association between the recalled product and the injury rather than another underlying condition, surgical complication, or known medication effect.

What Evidence Should I Keep If I Used Recalled Eye Drops?

Keep the bottle and original packaging whenever possible. Do not discard the product merely because it has been recalled if you believe you suffered an injury. Photograph the bottle, label, NDC, lot number, and expiration date. Preserve pharmacy receipts, prescription records, recall correspondence, medical bills, insurance statements, and records documenting subsequent eye treatment. This information can help establish product identification, exposure, injury, and damages.

Can I Have a Claim If I No Longer Have the Bottle?

Possibly. Losing or discarding the bottle does not necessarily eliminate a potential claim. Pharmacy dispensing records, insurance claims, electronic prescription records, medical records, purchase histories, and other documentation may identify the manufacturer or product dispensed. Product identification can become more difficult without the bottle, however, which is why anyone who still possesses the medication should preserve it.

How Long Do I Have to File a Prednisolone Acetate Eye Drop Lawsuit?

The deadline depends upon the state law govrning the claim and the individual circumstances. Product liability statutes of limitations vary considerably, and rules governing when a claim accrues can also differ. Patients should not assume that the recall date determines their filing deadline. An attorney can evaluate the applicable jurisdiction, date of injury, date the injury was discovered, and other relevant facts.

Injured After Using Recalled Prednisolone Acetate Eye Drops? Parker Waichman LLP Can Review Your Case

Patients have a right to expect prescription eye medications to be manufactured according to appropriate safety and quality standards. When an ophthalmic drug is recalled because of a reported foreign substance, people who suffered serious eye injuries may have questions about what happened, who may be responsible, and whether compensation is available.

Parker Waichman LLP is a national personal injury law firm representing individuals and families in product liability and pharmaceutical injury matters. If you or a family member used recalled prednisolone acetate ophthalmic suspension and subsequently developed an eye infection, severe inflammation, vision problems, or another significant injury, the circumstances should be investigated carefully.

An investigation can determine whether your medication corresponds with the recalled products, review medical evidence concerning the injury, identify potentially responsible parties, and determine which legal deadlines apply to your claim.

Parker Waichman LLP offers free consultations to potential clients nationwide. Call 1-800-YOUR-LAWYER (1-800-968-7529) to discuss a potential prednisolone acetate eye drop recall lawsuit. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.